Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01201083 · ClinicalTrials.gov registry record

Study of Recently HIV Infected Men and Transmission Behaviors

A clinical trial of HIV, sponsored by University of California, Los Angeles.

Completed
Registry status
600
Enrollment target
1
Study location

NCT01201083 is a study of HIV that has completed, run by University of California, Los Angeles. The registered enrollment target is 600 participants, above the 438-participant average among 303 other HIV trials with a reported enrollment target (37% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01201083, a study of HIV, has completed, sponsored by University of California, Los Angeles.

COMPLETED
Registry status
600 participants
Enrollment target
1
Study location

Study Summary

Identify drug use patterns and partnership dynamics that mediate risk behaviors over time in a cohort of recently HIV infected men and their partners; to determine predictors of transmission risk within partnerships of recently HIV infected men and their partners, using the partnership as the unit of analysis; and to quantify the long-term population-level impacts of voluntary behavior change by men with recent HIV infection, through the use of dynamic mathematical modeling that integrates our data on behavior change with current estimates of temporal infectiousness patterns. The investigators will also determine whether more frequent testing and/or development of tests with earlier sensitivity may have a significant impact on the epidemic. Finally, the magnitude of this effect to that obtained by decreasing drug use or risky sexual behavior prior to or following seroconversion will be compared. This will be conducted as a statistical analysis by co-investigators at the University of Washington.

Conditions Studied

Study Locations (1)

California

  • Los Angeles Gay and Lesbian Center - Los Angeles

Trial Details

FieldValue
Enrollment Target 600 participants
Start Date 2009-02
Est. Completion 2018-08

What the Registry Record Tells You About NCT01201083

The ClinicalTrials.gov registry entry for NCT01201083 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 600 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 438-participant average among 303 other HIV trials with a reported enrollment target (37% higher). The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with HIV appearing as the primary indexed condition, and to 0 interventions.

NCT01201083 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT01201083 about?

NCT01201083 is a clinical study titled "Study of Recently HIV Infected Men and Transmission Behaviors". Identify drug use patterns and partnership dynamics that mediate risk behaviors over time in a cohort of recently HIV infected men and their partners; to determine predictors of transmission risk within partnerships of recently HIV infected men and their partners, using the partnership as the unit o...

What is the current status of trial NCT01201083?

This trial is currently completed. The enrollment target is 600 participants. The study started on 2009-02. Estimated completion is 2018-08.

What conditions does trial NCT01201083 study?

This clinical trial studies the following conditions: HIV.

Who is sponsoring clinical trial NCT01201083?

This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01201083 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for HIV

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.